You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) Antibodies

Full name:
anti-Luteinizing Hormone/choriogonadotropin Receptor Antibodies (LHCGR)
On www.antibodies-online.com are 165 Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) Antibodies from 20 different suppliers available. Additionally we are shipping Luteinizing Hormone/choriogonadotropin Receptor Proteins (20) and Luteinizing Hormone/choriogonadotropin Receptor Kits (12) and many more products for this protein. A total of 199 Luteinizing Hormone/choriogonadotropin Receptor products are currently listed.
Synonyms:
CDW44, CSPG8, ECMR-III, Gpcr19-rs1, GTHR-II, HCELL, HHG, HUTCH-I, IN, LCGR, LGR2, LH-R, LH/CG-R, LH/CGR, LHCGR, Lhr, LHRHR, LOC100222883, LOC100305044, LSH-R, LSHR, MC56, MDU2, MDU3, MIC4, Pgp1, ULG5, zfGTHR-II
list all antibodies Gene Name GeneID UniProt
LHCGR 960 P16070
LHCGR 16867 P30730
LHCGR 25477 P16235

Show all species

Show all synonyms

Most Popular Reactivities for anti-Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) Antibodies

Select your species and application

anti-Human Antibodies:

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-Luteinizing Hormone/choriogonadotropin Receptor Antibodies

Go to our pre-filtered search.

Top referenced anti-Luteinizing Hormone/choriogonadotropin Receptor Antibodies

  1. Human Polyclonal LHCGR Primary Antibody for IHC (p) - ABIN270629 : Yung, Aviel-Ronen, Maman, Rubinstein, Avivi, Orvieto, Hourvitz: Localization of luteinizing hormone receptor protein in the human ovary. in Molecular human reproduction 2014 (PubMed)
    Show all 3 references for ABIN270629

  2. Rat (Rattus) Polyclonal LHCGR Primary Antibody for WB - ABIN336206 : Berndt, Perrier dHauterive, Blacher, Péqueux, Lorquet, Munaut, Applanat, Hervé, Lamandé, Corvol, van den Brûle, Frankenne, Poutanen, Huhtaniemi, Geenen, Noël, Foidart: Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006 (PubMed)

  3. Human Polyclonal LHCGR Primary Antibody for ELISA, WB - ABIN190901 : Bukovsky, Indrapichate, Fujiwara, Cekanova, Ayala, Dominguez, Caudle, Wimalsena, Elder, Copas, Foster, Fernando, Henley, Upadhyaya et al.: Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and ... in Reproductive biology and endocrinology : RB&E 2004 (PubMed)

  4. Human Polyclonal LHCGR Primary Antibody for IHC (p) - ABIN122503 : Sand, Bergvall, Ekblad, DAmato, Ohlsson: Expression and distribution of GnRH, LH, and FSH and their receptors in gastrointestinal tract of man and rat. in Regulatory peptides 2013 (PubMed)

  5. Human Polyclonal LHCGR Primary Antibody for IF (p), IHC (p) - ABIN873328 : Yang, Dou, Zhang, Gu, Lv, DU, Ba, Mu, Lu: Increased 3β-hydroxysteroid dehydrogenase 2 and 17α-hydroxylase activities in a virilized adolescent female with adrenal adenoma: A case report. in Experimental and therapeutic medicine 2016 (PubMed)

More Antibodies against Luteinizing Hormone/choriogonadotropin Receptor Interaction Partners

Zebrafish Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) interaction partners

  1. Data show that double mutation of follicle-stimulating hormone receptor (fshr (show FSHR Antibodies)) and luteinizing hormone receptor (lhcgr) resulted in infertile males

  2. Data show for the first time in a vertebrate species that Leydig cells as well as Sertoli cells express the mRNAs for both fshr (show FSHR Antibodies) and lhcgr.

Horse (Equine) Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) interaction partners

Human Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) interaction partners

  1. Of the 22 single nucleotide polymorphisms studied, the rs8193 polymorphism lying in the micro-RNA binding site of 3'-UTR (show UTS2R Antibodies) of CD44 (show CD44 Antibodies) was significantly (P=.0270) associated with RT-induced adverse skin reactions. Generalized multifactor dimensionality reduction analysis showed significant (P=.0107) gene-gene interactions between MAT1A (show MAT1A Antibodies) and CD44 (show CD44 Antibodies). Furthermore, an increase in the total number of risk alleles was associated with in

  2. The crystal structure of the lectin and EGF (show EGF Antibodies)-like domains of human L-selectin (show SELL Antibodies) is solved at 1.9 A resolution.

  3. Inactivating mutations of the LHCGR gene may be a common cause of 46,XY primary amenorrhea.

  4. CD44V6 is part of a positive-feedback loop with TGFbeta1 (show TGFB1 Antibodies)/TGFbetaRI signaling that acts to increase NOX4 (show NOX4 Antibodies)/ROS (show ROS1 Antibodies) production, which is required for myofibroblast differentiation, myofibroblast differentiation, myofibroblast extracellular matrix production, myofibroblast invasion, and myofibroblast contractility.

  5. results indicate that the CD44 (show CD44 Antibodies) silencing-induced metabolic shift is mediated by the regulation of c-Src (show SRC Antibodies)/Akt (show AKT1 Antibodies)/LKB1 (show STK11 Antibodies)/AMPKalpha (show GRK4 Antibodies)/HIF-1alpha (show HIF1A Antibodies) signaling in human breast cancer cells

  6. used a next generation sequencing (NGS) approach. NY-SAR-35 expression induced growth, proliferation, metastasis, and stemness genes, as indicated by the up-regulations of CXCR4 (show CXCR4 Antibodies), EpCAM (show EPCAM Antibodies), CD133, and CD44 (show CD44 Antibodies), at the mRNA and protein levels

  7. CD44 (show CD44 Antibodies)+/24- and ALDH1 (show ALDH1A1 Antibodies)-positive rates in primary tumors differed according to intrinsic subtype. ER-positive patients with CD44 (show CD44 Antibodies)+/24- tumors had significantly longer disease-free-survival than all other ER-positive patients

  8. CD44 (show CD44 Antibodies) expression showed no significant association with neoadjuvant chemoradiotherapy response in esophageal adenocarcinoma.

  9. CD44 (show CD44 Antibodies)+/CD24 (show CD24 Antibodies)- cells were present in all tumor tissues. The percentage of CD44 (show CD44 Antibodies)+/CD24 (show CD24 Antibodies)- cells was higher in early-stage disease, but without statistical significance.

  10. study demonstrated the synergistic interactions between CD44 (show CD44 Antibodies) and TGF-beta1 (show TGFB1 Antibodies) in EMT (show ITK Antibodies) induction and CSC properties through the AKT (show AKT1 Antibodies)/GSK-3beta (show GSK3b Antibodies)/beta-catenin (show CTNNB1 Antibodies) pathway in HCC (show FAM126A Antibodies) cells

Mouse (Murine) Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) interaction partners

  1. FSHR (show FSHR Antibodies) and LHR proteins are significantly upregulated in CCs (show CCS Antibodies) surrounding oocytes arrested at the 2-cell stage, reflecting their developmental incompetence.

  2. Triptorelin and cetrorelix induce immune responses and affect uterine development and expressions of genes and proteins of ESR1 (show ESR1 Antibodies), LHR, and FSHR (show FSHR Antibodies)

  3. Data suggest that persistent cAMP signals from internalized luteinizing hormone receptor (LH receptors) contribute to transmitting LH effects inside follicle cells and ultimately to the oocyte.

  4. Demonstrate the presence of LH receptors. Activation resulted in a dose-dependent increase in glucose-induced release of insulin (show INS Antibodies).

  5. LHCGR signaling in regulating the Ahr (show AHR Antibodies) message involves protein kinase A pathway and is attributable to decreased transcription rate.

  6. Data from mutant mouse strain (gain-of-function mutation in LHR, D578G; most common mutation found in familial male-limited precocious puberty) confirm that LHR is critical for male steroidogenesis, gametogenesis, and Leydig cell development.

  7. LH/hCG (show CGA Antibodies) tightly up-regulates MKP-3 (show DUSP6 Antibodies) which in turn, dephosphorylates ERK1/2 (show MAPK1/3 Antibodies) and drives p21 (show D4S234E Antibodies) expression.

  8. Data suggest that Lhcgr in endometrium and luteinizing hormone in blastocyst are involved in embryo/blastocyst implantation; expression of Lhcgr is up-regulated in endometrial epithelium in estrus cycle at time of implantation readiness (estrus).

  9. Through the LHR, LH/hCG (show CGA Antibodies) tightly regulates MKP-2 (show DUSP4 Antibodies) expression, which modulates the induction of CYP11A1 (show CYP11A1 Antibodies) by 8Br-cAMP.

  10. Expression of LH receptor in nonpregnant mouse endometrium.

Cow (Bovine) Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) interaction partners

  1. The outcomes of the present study support a dynamic multi-facetted regulation of LHR during pre-translation.

  2. expression of LHR mRNA in bovine granulosa cells is established after follicle deviation, and the lower abundance of LRBP (show MVK Antibodies) mRNA after the expected time of deviation may contribute to greater expression of LHR in the bovine dominant follicle

  3. These results suggested an acute regulation of INSL3 (show INSL3 Antibodies) by luteinizing hormone (LH) because INSL3 (show INSL3 Antibodies) concentrations increased immediately after endogenous and exogenous LH stimulation.

  4. INVESTIGATION OF STAT5A (show STAT5A Antibodies), FSHR (show FSHR Antibodies) AND LHR GENE POLYMORPHISMS IN TURKISH INDIGENOUS CATTLE BREEDS

  5. These findings strongly support the concept that IGF-1 (show IGF1 Antibodies) upregulates LHR expression in granulosa cells and that IGF-1 (show IGF1 Antibodies) is required for determining which follicle becomes dominant and acquires ovulatory capacity.

  6. LHCGR mRNA expression in granulosa cells was significantly higher in large antral follicles than in cysts, and not detected in granulosa cells of small and medium antral follicles.

  7. The luteinizing hormone receptor [LHR] splicing pattern is complex in bovine Leydig cells, and expression of full-length LHR and isoforms A and B changes when induced with LH.

  8. The LHCGR gene is a potential marker for superovulation response and can be used to predict the most appropriate dose of FSH (show BRD2 Antibodies) for superovulation in Chinese Holstein cows.

  9. Dominant follicles experience a reduction in FSH (show BRD2 Antibodies) dependence (diminished expression of FSHR (show FSHR Antibodies)), but acquire increased LH dependence (enhanced expression of LHCGR) as they grow during the low FSH (show BRD2 Antibodies) milieu of follicular waves.

  10. Three single nucleotide polymorphisms in LHCGR were significantly associated with variations in cattle fertility and production traits.

Pig (Porcine) Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) interaction partners

  1. In porcine ovaries, MAb found 6 distinct LHR bands migrating at approximately 92, 80, 68, 59, 52 & 48 kDa. There is a possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders & Alzheimer's disease.

Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) Antigen Profile

Antigen Summary

This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia.

Alternative names and synonyms associated with Luteinizing Hormone/choriogonadotropin Receptor (LHCGR)

  • luteinizing hormone/choriogonadotropin receptor (lhcgr-A) antibody
  • luteinizing hormone/choriogonadotropin receptor (lhcgr) antibody
  • luteinizing hormone/choriogonadotropin receptor (LHCGR) antibody
  • luteinizing hormone/choriogonadotropin receptor (LOC100222883) antibody
  • luteinizing hormone receptor (LHR) antibody
  • luteinizing hormone receptor (lhr) antibody
  • luteinizing hormone receptor (LOC100305044) antibody
  • CD44 molecule (Indian blood group) (CD44) antibody
  • luteinizing hormone/choriogonadotropin receptor (Lhcgr) antibody
  • CDW44 antibody
  • CSPG8 antibody
  • ECMR-III antibody
  • Gpcr19-rs1 antibody
  • GTHR-II antibody
  • HCELL antibody
  • HHG antibody
  • HUTCH-I antibody
  • IN antibody
  • LCGR antibody
  • LGR2 antibody
  • LH-R antibody
  • LH/CG-R antibody
  • LH/CGR antibody
  • LHCGR antibody
  • Lhr antibody
  • LHRHR antibody
  • LOC100222883 antibody
  • LOC100305044 antibody
  • LSH-R antibody
  • LSHR antibody
  • MC56 antibody
  • MDU2 antibody
  • MDU3 antibody
  • MIC4 antibody
  • Pgp1 antibody
  • ULG5 antibody
  • zfGTHR-II antibody

Protein level used designations for LHCGR

luteinizing hormone receptor , lutropin-choriogonadotropic hormone receptor , luteinizing hormone/choriogonadotropin receptor , lutropin-choriogonadotropic hormone receptor-like , Lutropin-choriogonadotropic hormone receptor , CD44 antigen , GP90 lymphocyte homing/adhesion receptor , Hermes antigen , cell surface glycoprotein CD44 , chondroitin sulfate proteoglycan 8 , epican , extracellular matrix receptor III , hematopoietic cell E- and L-selectin ligand , heparan sulfate proteoglycan , homing function and Indian blood group system , hyaluronate receptor , phagocytic glycoprotein 1 , hypergonadotropic hypogonadism , lutropin/choriogonadotropin receptor , LH/CG-R , LSH-R , LH receptor , luteinizing hormone receptor 2 protein , luteinizing hormone receptor precursor variant 1 , luteinizing hormone receptor precursor variant 2 , lutropin-choriogonadotropin receptor

GENE ID SPECIES
378624 Xenopus laevis
402920 Danio rerio
481365 Canis lupus familiaris
715999 Macaca mulatta
100034043 Equus caballus
100222883 Taeniopygia guttata
100303684 Meleagris gallopavo
100380984 Xenopus laevis
100457164 Pongo abelii
443339 Ovis aries
100135989 Oncorhynchus mykiss
100136406 Salmo salar
100305044 Ictalurus punctatus
100529183 Oryzias latipes
100583593 Nomascus leucogenys
100615277 Pan troglodytes
960 Homo sapiens
3973 Homo sapiens
16867 Mus musculus
25477 Rattus norvegicus
281900 Bos taurus
395776 Gallus gallus
407247 Sus scrofa
101113228 Ovis aries
Selected quality suppliers for anti-Luteinizing Hormone/choriogonadotropin Receptor (LHCGR) Antibodies
Did you look for something else?